image
KalVista Pharmaceuticals, Inc. KALV
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 9.49
-3.16 %
$ 462 M
Market Cap
-2.74
P/E
INCOME STATEMENT
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-140 M OPERATING INCOME
-26.67%
Growth Rates
1Year -26.67%
3Years -34.34%
5Years -36.33%
7Years -30.04%
10Years -39.00%
-127 M NET INCOME
-36.31%
Growth Rates
1Year -36.31%
3Years -39.91%
5Years -43.50%
7Years -31.52%
10Years -36.41%
EFFICIENCY
Earnings Waterfall KalVista Pharmaceuticals, Inc.
image
Revenue 0
Cost Of Revenue 86.2 M
Gross Profit -86.2 M
Operating Expenses 54.3 M
Operating Income -140 M
Other Expenses -13.8 M
Net Income -127 M

Income Statement

Millions
Apr-2024 Apr-2023 Apr-2022 Apr-2021 Apr-2020 Apr-2019 Apr-2018 Apr-2017 Apr-2016 Apr-2015 Dec-2013 Dec-2012
REVENUE
Revenue 0 0 0 12.7 12.7 16.1 8.4 1.5 2.1 1.8 0.4 1.5
GROSS PROFIT
Cost Of Revenue 86.2 0.8 0.7 0.7 40.2 K 35 K 18.2 K 12.7 K 14.7 K 8.28 K 0 0
Gross Profit (86.2) (0.8) (0.7) 12.0 12.6 16.1 8.4 1.5 2.1 1.8 0.4 1.5
OPERATING INCOME
Operating Expenses 54.3 110.9 96.6 57.9 53.2 45.9 27.1 23.8 17.3 9.9 5.6 3.4
Selling, General and Administrative Expenses 54.3 30.6 26.4 16.6 13.0 10.9 8.9 11.2 2.7 1.6 1.4 1.4
Research and Development Expenses 86.2 80.3 70.2 41.3 40.2 35.0 18.2 12.7 14.7 8.3 4.2 2.0
Operating Income (140.4) (110.9) (96.6) (57.9) (40.5) (29.8) (18.7) (22.3) (15.2) (8.1) (5.2) (1.8)
PRE-TAX INCOME
Interest Income Expense 0 (18.0) 1.1 0 0 0 0 0 0 0 0.4 0.3
Total Other Income 5.3 18.0 14.3 11.7 11.3 9.1 2.9 3.7 3.7 0.9 (0.5) (0.2)
Pre-Tax Income (135.1) (92.9) (82.3) (46.2) (29.2) (20.7) (15.8) (18.6) (11.4) (7.2) (5.7) (2.1)
NET INCOME
Tax Provision (8.5) (18.1) (13.8) (1.8) (0.1) 0.1 (1.3) (5.1) (5.4) (0.9) 0.5 0.2
Net Income (126.6) (74.9) (68.5) (44.5) (29.1) (20.8) (15.8) (18.6) (11.4) (7.2) (5.7) (2.1)
EPS 3.44 2.68 2.8 2.33 1.64 1.38 1.53 1.92 2.4 6.17 7.83 2.83